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The expression of the 1,800-base-pair BamHI Z region of Epstein-Barr virus DNA was analyzed by
hybrid-selected translation with several DNA subclones and RNA from different cell lines. Furthermore, large
segments of the three reading frames extending in this area were expressed as fusion proteins into Escherichia
coli. The fusion proteins were partially purified and used to immunize rabbits. These sera were used to confirm
our mapping assignments and to identify the respective posttranslationally modified proteins in in vivo labeling
experiments. The reading frame BRLF1 (the first reading frame starting in the BamHI R fragment in leftward
orientation) encoded a 93- to 96-kilodalton (kDa) protein depending on the cell line. The molecular weight of
in vivo-labeled proteins was increased relative to that of in vitro-translated proteins, indicating that a
posttranslational modffication had occurred. The BZLF1 reading frame encoded a 35-kDa protein. It was
posttranslationally cleaved from a 38-kDa precursor in induced B95-8 and induced Raji cells and from a
40-kDa precursor in induced P3HR1 cells. In Raji cells superinfected with virus derived from P3HR1 cells, the
protein seemed to be expressed both from endogeneous Raji genomes and from infecting genomes. The
transcripts for the 93- to 96-kDa and the 35-kDa protein overlapped partially. The serum against the expressed
third reading frame BZLF2 specifically precipitated a 140-kDa protein. This reading frame contains only 650
nucleotides, and therefore further coding sequences were presumably spliced to BZLF2. The latter is deleted
in the Raji cell line; therefore, the observed 140kDa protein in superinfected Raji cells was expressed from
infecting P3HR1 genomes.
Epstein-Barr virus (EBV), a member of the herpesvirus
family, undergoes limited replication, presumably lifelong,
in the oropharynxes of most individuals following primary
infection (16, 28, 34). Viral DNA can also be demonstrated
lifelong in peripheral B lymphocytes of all seropositive
individuals. These latently infected lymphocytes acquire the
capacity for unlimited growth. In vitro, only B lymphocytes
can be infected. Cell lines established from such experi-
ments, from naturally infected peripheral lymphocytes, or
from Burkitt lymphoma biopsies, are the only EBV-positive
cell culture systems available. In these permanently growing
cell lines, the virus remains essentially latent and only a
limited set of viral genes is expressed. In some cell lines
(e.g., B95-8, P3HR1), a low percentage of the cells con-
stantly enter the productive cycle, and proteins from the
early and late stages of virus replication and infectious virus
are produced. The number of cells entering the lytic cycle is
dramatically increased after induction with various agents,
particularly with phorbol-12-mystrate-13-acetate (35) and
butyric acid (10). Some nonproducer cell lines, like Raji, can
be stimulated as well by these inducers to express viral
proteins of the lytic cycle. The Raji cells are exceptional in
that they produce only proteins of the early class. P3HR1
cells have two peculiarities: first, the produced virus is
incapable of transforming cells and, second, the virus prep-
arations contain a population of defective viruses. These
defective particles contain four EBV DNA segments that are
partially inverted and fused (3, 14, 26). The defective DNA
(het-DNA) is correlated with the capacity to induce the lytic
cycle from latent genomes, e.g., after the superinfection of
Raji cells (14, 24). The het-DNA BamHI Z area is fused in
the opposite orientation to sequences from the BamHI W
fragment (3, 6, 26). Transfection of a cloned subfragment of
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the het-DNA containing the fused BamHI W and Z frag-
ments into latent hybrid D98/HR-1 cells (6) or of a standard
BamHI Z fragment into Raji cells (30) trans-activates the
latent EBV genome, presumably by proteins expressed from
the transfected DNA.
By using hybrid-selected translation with RNA from in-
duced P3HR1 cells, we (27) and others (5) mapped several
proteins to the BamHI Z fragment. In further experiments,
we used RNA from induced Raji cells and could map to this
fragment proteins similar to that from P3HR1 cells but with
a slightly differing molecular weight (manuscript in prepara-
tion). It should be noted that the proteins identified by this
method are primary translation products (owing to the
absence of posttranslational modifications in the in vitro
translation system). Monospecific sera or monoclonal anti-
bodies are therefore necessary to positively identify which of
the in vivo-labeled EBV proteins examined in several labo-
ratories in terms of time-dependent synthesis, modification,
correlation to antigenic groups, and sensitivity to inhibitors
are encoded by the various genes.
In this paper, we describe the detailed examination of the
cell-line-specific expression of the BamHI Z reading frames.
By using hybrid-selected translation with several subclones
of this region and RNA from different cell lines, we could
correlate our previously mapped in vitro-translated proteins
to two of the reading frames and obtain basic information
about the transcriptional organization. The protein encoded
by the third reading frame, which is deleted in EBV- DNA of
the Raji strain (22), was not detectable by in vitro transla-
tion. We further expressed large parts of the three reading
frames in Escherichia coli and immunized rabbits with the
partially purified proteins. These rabbit sera were used in
immunoprecipitation reactions to assign the mapped pro-
teins to the single reading frames and to identify the respec-
tive posttranslationally modified proteins in in vivo labeling
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FIG. 1. Map of the BamHI Z area with a summary of the data. (A) DNA fragments used in the experiments. The figure gives the plasmids
used for hybrid-selected translation, the proteins mnapped to them, and the fragments of the EBV genome used for protein expression. The
BamHI e3 fragment was cloned in a pUR expression vector. This plasmid was simultaneously used for hybrid-selected translation and for the
expression of parts of the BZLF2 reading frame. Fragment Z453 is contained in a pUC vector (pCZ453) and was used in this form for hybrid
selection. The same fragment was also cloned into a pUR plasmid (pRZ453) for the expression of parts of the BZLF1 reading frame. The
BamHI Z and R fragments cloned in pBR322 (28) and the plasmid pCeZ1622 were used only for hybrid-selected translation. Fragment ZR1495
was cloned in pUC19 (pCZR1495) and used for hybrid-selected translation; it was also cloned in a pUR vector (pRZR1495) for the expression
of parts of BRLF1 reading frame. Fragments eZ1622 and ZR1495 were also cloned in M13, and the single-stranded phage DNA of clones
pPeZ1622 and pPZR1495 was used for hybrid-selected translation (see Materials and Methods). (B) Organization of the BamHI Z region.
Promotors ( *), polyadenylation signals (a), open reading frames (), and restriction enzyme sites (B, BamHI; X, XhoI; P, PstI; H,
HindIII) were deduced from sequence data (1). (C) Viral proteins encoded by the three reading frames and extension of the transcripts
according to the data obtained by hybrid-selected translation. The ends are punctured to show that the exact start and end are not defined.
experiments. The protein encoded by the third reading frame
was also identified by immunoprecipitation with the appro-
priate serum.
MATERIALS AND METHODS
RNA manipulations. Tissue culture, RNA preparation,
hybrid selection, and in vitro translation were done as
described previously (27). Briefly, the cells were lysed 2
days after induction (with 40ng of phorbol-12-mystrate-13-
acetate per ml plus 3 mM sodium butyrate) with 4 M
guanidine isothiocyanate-0.5 M 2-mercaptoethanol. The
RNA was isolated by sedimentation through a CsCl cushion
(1.8 g/cm3). For hybrid selection, the DNA was spotted on
small nitrocellulose filters and hybridized against the total
RNA. Bound RNA was eluted by boiling. The selected
mRNA was translated in vitro with a rabbit reticulocyte
lysate.
Cloning of hybridization probes. The DNA sequence of the
B95-8 strain (1) was analyzed with computer programs (7) for
restriction enzyme sites and reading frames. The DNA was
digested with the appropriate restriction enzymes (Boehr-
inger Mannheim GmbH, Mannheim, Federal Republic of
Germany) and run on agarose gels. Bands containing the
desired sequences were excised, eluted electrophoretically,
purified and concentrated with Elutip-d columns (Schleicher
& Schuell, GmbH, Dassel, Federal Republic of Germany),
ligated with T4 DNA ligase (Boehringer), and used to
transform bacteria as described by Hanahan (9).
The Sall C fragment of EBV strain M-ABA DNA cloned
in pHC79 (23) was digested with HindIlI and XhoI. A
1,495-base-pair (bp) fragment containing parts of the BamHI
Z and R fragments was ligated with Hindlll- and SalI-
digested pUC19 (19) to generate the plasmid pCZR1495 (Fig.
1). A 1,622-bp fragment covering the BamHI e3 fragment
and parts of the BamHI e2 and Z fragments was cloned
similarly to generate the plasmid pCeZ1622. The latter Was
digested with HindIII and PstI, and 453 bp of the BamHI Z
fragment were cloned in pUC19 as pCZ453.
The inserts of pCeZ1622 and pCZR1495 were cloned in
addition in M13mp8 (13). The single-stranded DNA of the
bacteriophage particles from the resulting M13 clones
pPeZ1622 and pPZR1495 resembles the opposite strands
because the fragments in the two clones are in opposite
orientation with respect to their restriction enzyme sites at
the ends.
Cloning for expression of EBV proteins as bacterial fusion
proteins. The theoretical secondary structure of the EBV
proteins superimposed by their hydrophilicity and hydro-
phobicity was calculated with a computer program written in
our laboratory following suggestions by E. Golub and G.
Cohen (4). Potential antigenic sites which are preferentially
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in hydrophilic ,-turns were included in the expressed por-
tions of the EBV proteins (for a detailed description, see
reference 17).
The EBV proteins were expressed as fusion proteins with
P-galactosidase in pUR plasmids (25). The viral reading
frames were inserted in frame near the C terminus of the
P-galactosidase reading frame. The BamHI e3 fragment was
excised from pCeZ1622 and ligated with pUR278. In the
resulting plasmid pRe3-521 (BamHI e3), which was also used
for hybrid selection, the C-terminal 165 amino acids of the
670-bp BZLF2 frame were expressed. The end of the BZLF2
frame is within the BamHI e3 fragment, and therefore the
fusion protein ends with the EBV sequence. For the expres-
sion of the BRLF1 reading frame, the EBV-derived se-
quence of pCZR1495 was excised with HindlIl and XbaI and
ligated with pUR288. In the resulting plasmid pRZR1495,
again the 3' part of the BRLF1 reading frame is fused in
frame to the ,-galactosidase reading frame with a few
nucleotides from the pUC vector in between. The last 400
amino acids of the 1,800-bp BRLF1 frame were expressed
with the EBV-encoded part again at the end of the fusion
protein.
The reading frame BZLF1 contains one probably prefer-
ential antigenic site between amino acids 150 and 175. The
expression of the appropriate sequences in a pUR vector
was only possible after insertion of the EBV-derived se-
quences of pCZ453 after a HindIII-XbaI digest in PINIII Bi
(11). From there, the EBV sequences were excised with
BamHI and XbaI and ligated with pUR289. In the resulting
plasmid pRZ453, the last 330 nucleotides of the 600-bp
BZLF1 reading frame were fused to the P-galactosidase
reading frame with a few nucleotides of PINIII Bi in
between.
Expression and purification of the fusion proteins. The
expression plasmids were transformed in E. coli JM103 (12).
This strain represses the transcription of the fusion reading
frame by overproduction of the lac repressor. Transcription
was induced with 1 mM isopropyl-p-D-thiogalactopy-
ranoside after the bacteria had grown to an optical density of
0.9. The bacteria were grown for another 2 to 4 h, sedi-
mented, digested with lysozyme, and sonicated. After addi-
tion of 3% Triton X-100, the bacterial lysate was sedimented.
Most of the bacterial proteins were dissolved in the super-
natant. The expressed fusion proteins were found predomi-
nantly in the insoluble pellet. The pellet was dissolved in 8 M
urea-20 mM Tris (pH 8.0)-0.5% mercaptoethanol and cen-
trifuged again. The supernatant with the dissolved fusion
proteins was subsequently dialyzed against 6, 4, and 3 M
urea. Two bacterial proteins precipitated and could be
separated by sedimentation. The 3 M urea supernatant was
dialyzed against phosphate-buffered saline, which led to the
precipitation of a high portion of the fusion proteins as
determined by a comparison to the supernatant. The precip-
itated fusion proteins could be isolated by sedimentation and
were used for immunizing the rabbits.
Immunoprecipitation, polyacrylamide gel electrophoresis,
and Western blotting. Raji cells were superinfected with
virus isolated from P3HR1 cells as described previously (2).
At 12 h postinfection, the cells were labeled for 4 h with 50
,uCi of [35S]methionine per ml. The induced cell lines were
labeled 2 days after induction for 16 h with 20 pCi of
[35S]methionine per ml. The cells were subsequently washed
and lysed in immunoprecipitation buffer (1% Triton X-100,
0.1% sodium dodecyl sulfate, 0.137 M NaCl, 1 mM CaCl2, 1
mM MgCl2, 10% glycerol, 20 mM Tris [pH 9.0], 0.01%
NaN3, 1 mM phenylmethylsulfonyl fluoride). The lysate of
106 cells was incubated with 5 to 10 ,ul of serum preadsorbed
with an unlabeled protein extract from 107 EBV-negative
BJA cells. The immune complexes were bound on protein
A-Sepharose beads (Pharmacia, Uppsala, Sweden) washed,
eluted by boiling in 2% sodium dodecyl sulfate-3%
sucrose-5% mercaptoethanol-20 mM Tris (pH 7.0)-
bromphenol blue, and subjected to polyacrylamide gel elec-
trophoresis as described previously (2). For Western blot-
ting, unlabeled proteins were separated in polyacrylamide
gels and electrophoretically transferred onto nitrocellulose
(BA85; Schleicher & Schuell). The nitrocellulose was prein-
cubated with a modified Deinhardt solution (4) for 2 h and
incubated overnight at room temperature with the 1:50
diluted serum. The blots were washed with gelatin buffer (50
mM Tris [pH 7.5], 5 mM EDTA, 150 mM NaCl, 0.25%
gelatin, 0.5% Triton X-100, 0.1% sodium dodecyl sulfate)
and incubated for another 2 h with peroxidase-labeled anti-
bodies against human immunoglobulins (Dakopatts, GmbH,
Hamburg, Federal Republic of Germany). After subse-
quently being washed with gelatin buffer, the blot was
developed with 0.5 mg of 3,3'-diaminobenzidine per ml and
0.01% H202-50 mM Tris (pH 7.6).
RESULTS
Fine mapping of the BamHI Z area with hybrid-selected
translation. To analyze the complex protein pattern obtained
after hybrid-selected translation with the BamHI Z fragment
and P3HR1 RNA (27), we constructed several subclones.
Clones pCeZ1622 and pCZR1495 represent the left and the
right half of the BamHI Z fragment, respectively, with
adjacent sequences. BamHI-e3 (pRe3-521) is the fragment to
the left of BamHI-Z and contains mainly sequences from the
BZLF2 reading frame. Fragment pCZ453 from the central
area of the BamHI Z fragment contains sequences from the
BZLF1 reading frame only.
RNA from induced P3HR1 cells, induced B95-8 cells,
induced 883L cells, and induced Raji cells was used for
hybrid selection with the previously mentioned plasmids
and, in addition, with the BamHI R and Z fragments from
strain B95-8 (29). No specific protein above the background
could be detected after hybrid-selected translation with the
BamHI e3 fragment (Fig. 2). All other fragments tested
hybridized with the mRNA for a protein ranging in size from
92 to 96 kilodaltons (kDa) in the different cell lines. With
RNA from induced P3HR1 cells, induced Raji cells, and
induced B95-8 and 883L cells, 92-, 96-, and 94-kDa proteins,
respectively, could be translated in vitro. The size differ-
ences were reproducible and were clearly visible in many
independent experiments (see Fig. 7). Minor bands in the
range of 75 to 83 kDa could be detected in all of these
hybrid-selected translations, with a similar size distribution
among the different cell lines.
The mRNA for the 80-kDa protein mapped previously in
the BamHI R and K fragments (27) hybridized as expected
with the BamHI R fragment. However, it did not hybridize
to the left segment of the BamHI R fragment contained in the
plasmid pCZR149S. Therefore, the protein is encoded by one
of the rightward reading frames in the BamHI R or K
fragment, presumably by the BRRF2 reading frame, accord-
ing to the sequence data. The protein could only be detected
with RNA from induced P3HR1 and particularly from in-
duced B95-8 cells, not from induced 883L cells, owing to
different responses of the individual cell lines to the induc-
tion. In the Raji cells, which could also be induced to a
reasonable extent, the protein could not be detected in many
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FIG. 2. Hybrid-selected translation with RNAs from induced P3HR1 cells (lanes 1), induced B95-8 cells (lanes 2), induced 883L cells (lanes
3), induced Raji cells (lanes 4), and the DNA fragments indicated. In the left two panels, single-stranded DNA probes from M13 phages
representing opposite strands were used. The bound mRNAs and samples of unselected RNA including RNA from EBV-negative BJA cells
(lanes 5) as control were translated in vitro with reticulocyte lysate and [35S]methionine as radioactive amino acid. The translation products
were immunoprecipitated with a pool of sera from NPC patients and separated on sodium dodecyl sulfate-polyacrylamide gels. The gels were
dried, fixed, and exposed to 3H-Ultrofilm (LKB Instruments, Bromma, Sweden). Owing to the different numbers of induced cells in the
various cell lines, the intensity of the mapped proteins and of the background proteins varied. With RNA from induced B95-8 cells, the most
intense signals could be achieved, but the background was also increased owing to overexposure (to make the very thin signals with RNA
of induced 883L cells visible). All of the proteins detectable after hybridization with the BamHI e3 fragment represent background proteins.
The prominent 23-kDa protein visible after hybridization with all fragments, especially with B95-8 RNA, is encoded by the BLRF1 or the
BLRF2 reading frame, or both, in the BamHI L fragment (R. Seibl and H. Wolf, unpublished results).
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FIG. 3. Coomassie-stained electrophoretically separated bacte-
rial proteins. Bacteria without plasmid (lanes 1), harboring a pUR
vector without EBV DNA inserted (lanes 2), or harboring the EBV
expression plasmids with the different reading frames fused to the
,-galactosidase reading frame (lanes 3) were induced to express the
proteins controlled by the lac promoter, lysed, and subjected to
electrophoresis. 1-Galactosidase was also included in the marker
protein mixture (116 kDa). The expressed P-galactosidase from the
pure pUR plasmid can easily be identified by comparison with the
bacteria lacking the plasmid. The fusion proteins were a mixture of
proteins translated at full length and proteins in which the EBV
segment is present in amounts varying from a few amino acids to
nearly full length, as indicated by a smear of proteins above the
116-kDa marker with accumulations at certain preferential molecu-
lar masses. The distribution of the different sizes was characteristic
for the expressed amino acid sequences. In the purification process,
the bacterial lysate was made 3% with Triton X-100 and the soluble
part of the lysate (lanes 4) was discarded. The insoluble part was
dissolved in 8 M urea and subsequently dialyzed against 3 M urea.
Two bacterial proteins insoluble in 8 M (lanes 5) and 3 M (lanes 6)
urea could be separated. The fusion proteins remained dissolved in
experiments, indicating that the 80-kDa protein may be a late
protein.
From induced Raji, induced B95-8, and induced 883L
cells, the mRNA for a protein of 38 kDa hybridized to the
plasmids pCZR1495, pCZ453, BamHI-Z, and pCeZ1622.
Occasionally, the protein was resolved as a double band of
38 and 37.5 kDa. With RNA from induced P3HR1 cells, in
contrast, a double band of 40 and 39 kDa could be translated
after hybridization to the same fragments. To analyze the
direction of the transcription, we cloned fragments ZR1495
and eZ1622 into M13mp8 and used single-stranded DNA
from phage particles for hybrid-selected translation with
P3HR1 RNA. With DNA probes containing both strands of
the respective DNA fragments (pCZR1495 and pCeZ1622),
the identical pattern of all the proteins encoded by the
BamHI Z fragment could be detected. The single-stranded
DNA of the M13 clones represents strands of opposite
polarity. pPZR1495 single-stranded DNA, which is in the
leftward orientation, did not hybridize to any of the trans-
latable mRNAs. With pPeZ1622 single-stranded DNA, a
rightward strand, all the proteins could be detected.
In conclusion, the mRNAs for the 92- to 96-kD and the 38-
and 40-kDa proteins both ran in a leftward direction. Only
DNA fragments containing sequences from the BZLF1
reading frame hybridized with the transcripts for the 38- and
40-kDa proteins. All fragments containing sequences from
the BRLF1 reading frame, as well as fragment pCZ453,
hybridized with the transcripts for the 92- to 96-kDa pro-
teins. Therefore, it was necessary to prepare monospecific
sera against the polypeptides encoded by the different read-
3 M urea (lanes 7) and could be precipitated by dialysis against
phosphate-buffered saline (lanes 8), in which only limited amounts
remained in solution (lanes 9).
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ing frames to furnish more detailed information on the
proteins encoded by them.
Expression of the open reading frames in bacteria. Large
segments of the three open reading frames BRLF1, BZLF1,
and BZLF2 were expressed as fusion proteins in E. coli.
Expression and purification of the proteins were controlled
by Coomassie staining (Fig. 3) and Western blotting (Fig. 4)
of polyacrylamide gels. The Western blots were probed with
a serum pool from nasopharyngeal carcinoma (NPC) pa-
tients. The fusion proteins reacted more strongly than did
pure P-galactosidase, which was similarly expressed from
pUR plasmids. Therefore, antibodies against the polypeptide
fused to the ,-galactosidase are present in the sera, in high
titer in the case of BZLF2 and BZLF1. All three reading
frames are correctly expressed from the pUR plasmids in the
bacteria and are also expressed from the viral DNA in NPC
patients because antibodies against the proteins are present,
as also shown below by immunoprecipitation of the BRLF1
and BZLF1 proteins by the serum pool.
The fusion proteins were purified by a simple and efficient
method based upon the relative insolubility of 1-
galactosidase fusion proteins. Nearly all the bacterial pro-
teins were soluble in the bacterial lysate with 3% Triton
X-100. The mainly insoluble fusion proteins were dissolved
in 8 M urea-0.5% mercaptoethanol. After dialysis against 3
M urea, another two bacterial proteins could be separated.
Most of the still-dissolved fusion proteins precipitated upon
dialysis against phosphate-buffered saline, and this sediment
was used to immunize rabbits.
Identification of the protein encoded by the BZLF2 reading
frame. After in vivo labeling of induced P3HR1, induced
B95-8, and superinfected Raji cells, a protein of 140 kDa
could be specifically precipitated by the serum of a rabbit
immunized with the expressed BZLF2 protein (Fig. 5). As
expected, the protein could not be detected in induced Raji
cells (data not shown), since the reading frame is deleted in
EBV DNA from the Raji strain (22). Therefore, in
superinfected Raji cells, the 140-kDa protein was expressed
from infecting P3HR1 genomes. No protein could be precip-
itated from in vitro translations, in accordance with the
negative result of the hybrid-selected translations with the
Bam Hi e3 pRZR1495
pRZ453
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FIG. 4. Wester blot of the bacteral lysates and some purifica-
tion steps described in the legend to Fig. 3. Probes identical to those
described in the legend to Fig. 3 were separated in polyacrylamide
gels and blotted on nitrocellulose. The blot was immunostained with
a pool of sera from NPC patients.
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FIG. 5. Immunoprecipitation with rabbit serum against the
BZLF2 protein. Induced P3HR1, induced B95-8, superinfected Raji,
and Raji cells were labeled in vivo with [35S]methionine. The
negative serum of the rabbit prior to immunization (-) and the
immune serum (+) were used in parallel for immunoprecipitation.
An in vitro translation (T) of RNA from induced P3HR1 cells
immunoprecipitated with the NPC serum pool (P) was run in parallel
as marker. The two prominent proteins in the 140-kDa molecular
mass range are the 138-kDa protein encoded by the BALF2 reading
frame (17) and the 143-kDa protein encoded by the BNRF1 reading
frame (27).
BamHI e3 fragment. The most likely explanation for this is
that the BZLF2 protein belongs to the group of proteins
which can be more effeciently labeled by in vivo translation
than by in vitro translation, which is similar to the situation
with the BZLF1 protein. Other proteins, e.g., the BRLF1
protein, behave in the opposite manner. If the BZLF2
protein belonged to the first group, the in vitro translation
product would be below the detection limit, because the
protein is already very weak in in vivo labeling experiments.
Identification of the protein encoded by the BZLF1 reading
frame. The serum of the rabbit immunized with the ex-
pressed BZLF1 protein specifically immunoprecipitated the
40- and 39-kDa proteins from in vitro translations of RNA
from induced P3HR1 cells and the 38-kDa protein from in
vitro translations of RNA from induced B95-8 and induced
Raji cells (Fig. 6). From extracts of in vivo-labeled induced
B95-8, induced Raji, induced P3HR1, and superinfected Raji
cells, a protein of 35 kDa could be immunoprecipitated.
Small amounts of the 38- and 40-kDa primary translation
products were also detectable. The protein seemed to be
posttranslationally cleaved. The additional sequences of the
P3HR1 protein seemed to be removed as well. In the
superinfected Raji cells, both the 38- and the 40-kDa precur-
sor protein were visible, indicating that the gene might be
expressed from infecting P3HR1 as well as endogeneous Raji
genomes.
Identification of the protein encoded by the BRLF1 reading
frame. By using the serum against the BRLF1 polypeptide,
the mapped in vitro-translated proteins of 96, 94, and 92 kDa
with RNA from induced Raji cells, induced B95-8 cells, and
induced P3HR1 cells, respectively, could be precipitated
(Fig. 7). From in vivo-labeled induced B95-8 and induced
J. VIROL.
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FIG. 6. Immunoprecipitation with the rabbit serum against the
BZLF1 protein. The negative serum of the rabbit prior to immuni-
zation (-) and the immune serum (+) were used in parallel to
immunoprecipitate in vitro translations (T) of RNA from induced
B95-8 and induced P3HR1 cells and extracts of in vivo-labeled (V)
induced B95-8, induced P3HR1, superinfected Raji, and induced
Raji cells. An in vitro translation (T) of unselected RNA from
induced P3HR1 cells immunoprecipitated with the NPC serum pool
(P) was run in parallel. The serum pool was also used to immuno-
precipitate in vivo-labeled superinfected Raji cells, in which the
35-kDa band consists of more than one polypeptide (2). The same is
true for the 40-kDa band precipitated by the serum pool from in vitro
translations of RNA from induced P3HR1 cells (27).
P3HR1 cells, proteins with molecular masses slightly higher
than those of proteins from the corresponding in vitro
translation experiments were precipitated. The protein
seemed to be posttranslationally modified by the addition of
an unknown component. In the induced Raji cells, the
protein had the same molecular mass after in vivo or in vitro
translation according to sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis.
96F _
DISCUSSION
We analyzed the transcription and translation of the EBV
BamHI Z area in different cell lines. This region is charac-
terized by considerable strain-specific protein polymor-
phism. These differences enabled us to demonstrate that in
superinfected Raji cells, both the endogeneous Raji genome
and the infecting P3HR1 genomes (standard or defective)
seem to be expressed in the BamHI Z area.
In contrast to the other cell lines tested, no difference in
the expression of B95-8 and 883L cells was observed. B95-8
cells have been established by in vitro transformation of
marmoset lymphocytes with virus derived from the 883L cell
line (15). The expression of the BamHI Z area remained
stable throughout the propagation of the cell lines. This may
indicate that the observed protein polymorphism represents
strain-specific variations already present in the patients from
which the cell lines were established and does not reflect
consequences of propagation in cell cultures. Similar strain
polymorphism has been reported for herpes simplex virus
(20).
The three open reading frames of this area were expressed
as fusion proteins with P-galactosidase in E. coli. This
approach was chosen because expression of pure eucaryotic
proteins in bacteria is, in many cases, not efficient, owing to
degradation by proteases or incomplete translation. Even in
the P-galactosidase fusion proteins, the viral segment is
frequently not synthesized at full length. A further advantage
of the expression as I-galactosidase fusion protein is the
possibility of rapid and efficient purification by successive
precipitation. These protein preparations were used to im-
munize rabbits to generate sera which specifically recognize
the protein(s) encoded by the appropriate reading frame.
The reading frame BRLF1 encodes a protein of 93 to 96
kDa, depending on the cell line. Additionally, smaller pro-
teins in the range of 75 to 83 kDa could be mapped to this
reading frame. These presumably represent shorter transla-
tion products due to truncated mRNAs, which appear in the
hybrid-selected translation as indicated by Northern blotting
of selected and unselected RNA (data not shown). The
BRLF1 protein is posttranslationally modified, at least in
induced B95-8 and induced P3HR1 cells, because smaller
proteins were precipitated from in vitro translations than
from in vivo-labeled cells. The molecular mass calculated
from the sequence of the open reading frame is only 67 kDa.
It cannot be ruled out that additional small coding sequences
from elsewhere on the genome, which would not be detected
under the stringent hybrid selection conditions or other
coding sequences in the BamHI Z and R fragments, are
fused to BRLF1 by splicing. This seems, however, not very
likely, because similar differences in the calculated molecu-
lar mass and that obtained by polyacrylamide gel electro-
T V
T_ _
co
LS:
a -=
I
T V
a,
V T
.=- Z;(C,,
ccC tL a:1r 1
T T V V
+ + P
492 92
a
FIG. 7. Immunoprecipitation with the serum against the BRLF1
protein. The negative serum of the rabbit prior to immunization (-)
and the immune serum (+) were used in parallel to immunoprecip-
itate in vitro translations (T) of RNA from induced Raji, induced
B95-8, and induced P3HR1 cells and in vivo-labeled extracts (V) of
the same cells and of superinfected Raji cells. In vivo-labeled
superinfected Raji cells immunoprecipitated with the NPC serum
pool (P) were run in parallel.
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phoresis are known from other reading frames. According to
our hybridization data, the transcript extends from the
BamHI R fragment to the BamHI Z fragment between
nucleotides 101750 and 102700. Sequence analysis has re-
vealed the existence of two TATA boxes near the 5' end of
BRLF1, as well as two suitable downstream polyadenylation
sites (1).
The reading frame BZLF1 encodes a 35-kDa protein. The
protein is translated into a 38-kDa precursor and seems to be
subsequently cloven. In P3HR1 cells, the precursor has a
molecular mass of 40 kDa, whereas the protein identified by
in vivo labeling is of the normal size. In in vitro translation
assays, the 35-kDa protein was not detectable, but a second
band of 39 kDa in P3HR1 cells and 37.5 kDa in B95-8 and
Raji cells, respectively, was seen. The processing may start
in the in vitro translation assays but cannot be completed
there. The calculated size of the protein, according to the
sequence of BZLF1, is only 21 kDa. Therefore, it is possible
that other reading frames contribute to this protein. The
transcript does not hybridize to the neighboring fragments of
BamHI-Z. One of the polyadenylation sites discussed for the
BRLF1 transcript may be used.
The reading frame BZLF2 encodes a 140-kDa protein;
however, the calculated size of the protein translated from
BZLF2 is only 25 kDa. Therefore, other coding sequences
are presumably spliced to this frame. The 5' end of the amino
acid sequence encoded by BZLF2 consists of a hydrophobic
domain which fulfills the criteria of a signal peptide consen-
sus sequence (21, 31, 32). Signal peptides are responsible for
the vectorial translation of secretory and membrane pro-
teins. The 140-kDa EBV membrane protein, reported from
several laboratories (8, 18, 33), may be partially encoded by
BZLF2.
With the specific sera against the proteins encoded by the
BamHI Z area modification, time-dependent synthesis and
cellular localization of the proteins are now accessible for
examination, and their role in the trans-induction of latent
EBV genomes can be studied.
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